TFE3 fusion proteins are the oncogenic drivers of translocation renal cell carcinoma but their mechanism of action remains ...

In a comprehensive experimental study, an international team of researchers has confirmed the calculations of a leading ...

Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...

Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...

SummerSounds, a free outdoor concert series at Greensburg’s St. Clair Park, will feature several tribute bands and Sudanese ...

In a groundbreaking advancement for families grappling with the challenges of Dravet syndrome, a rare and life-altering form ...

Fusion energy, the process of fusing light atomic nuclei to generate energy, has long been considered the key to a clean and ...

Lytgobi is an FGFR inhibitor that received accelerated approval in 2022 to treat adults with previously treated, unresectable ...